Odyssey Therapeutics Secures $25M Private Placement Concurrent with IPO

summarizeSummary

Odyssey Therapeutics completed a $25 million private placement with TPG at its IPO price, bolstering its capital position as it transitions to a public company.

check_boxKey Events

• Private Placement Completed

  Odyssey Therapeutics sold 1,388,889 shares of common stock to TPG LSI Rise Orazio II, L.P., an affiliate of an existing stockholder, for a total of $25,000,002.

• Pricing at IPO Level

  The shares were sold at $18.00 per share, matching the initial public offering price and representing a premium to the current market price of $17.45.

• Concurrent with IPO

  The private placement closed concurrently with the company's initial public offering, providing additional capital as the company went public.

• Corporate Governance Established

  The company filed an amended and restated certificate of incorporation and adopted amended and restated bylaws, effective May 11, 2026, in connection with its IPO.

auto_awesomeAnalysis

This filing details a significant $25 million private placement of common stock to an affiliate of an existing institutional stockholder, TPG, at the initial public offering price of $18.00 per share. This transaction closed concurrently with the company's IPO, providing additional capital and demonstrating strong institutional support for the newly public entity. The private placement price is also at a premium to the current market price of $17.45. The filing also includes standard amendments to the company's corporate charter and bylaws, establishing the governance framework for a public company.